These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 280159)

  • 21. Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.
    Brockman RW; Schabel FM; Montgomery JA
    Biochem Pharmacol; 1977 Nov; 26(22):2193-6. PubMed ID: 563233
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and biological evaluation of isomeric dinucleoside monophosphates and monomethylphosphonates of 9-beta-D-arabinofuranosyladenine and related analogues.
    Puech F; Gosselin G; qalzarini J; De Clercq E; Imbach JL
    J Med Chem; 1988 Oct; 31(10):1897-907. PubMed ID: 2459384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL; Shaddix SC; Brockman RW; Bennett LL
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.
    Dow LW; Bell DE; Poulakos L; Fridland A
    Cancer Res; 1980 May; 40(5):1405-10. PubMed ID: 6245791
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
    Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E
    Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells.
    LePage GA
    Cancer Res; 1978 Aug; 38(8):2314-6. PubMed ID: 580902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 2-amino-2-deoxy-beta-D-arabinofuranosyl nucleosides.
    Sato A; Imai R; Nakamizo N; Hirata T
    Chem Pharm Bull (Tokyo); 1979 Mar; 27(3):821-3. PubMed ID: 554746
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase.
    Lipper RA; Machkovech SM; Drach JC; Higuchi WI
    Mol Pharmacol; 1978 Mar; 14(2):366-9. PubMed ID: 642934
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells.
    Allaudeen HS; Kozarich JW; Sartorelli AC
    Nucleic Acids Res; 1982 Feb; 10(4):1379-87. PubMed ID: 6175955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of some novel phosphate and phosphinate derivatives of araA. Studies on the mechanism of action of phosphate triesters.
    McGuigan C; Shackleton JM; Tollerfield SM; Riley PA
    Nucleic Acids Res; 1989 Dec; 17(24):10171-7. PubMed ID: 2602149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
    Plunkett W; Cohen SS
    Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular retention of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and the pattern of recovery of DNA synthesis in Chinese hamster ovary cells.
    Shewach DS; Plunkett W
    Cancer Res; 1986 Apr; 46(4 Pt 1):1581-4. PubMed ID: 2418951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems.
    Müller WE; Zahn RK; Bittlingmaier K; Falke D
    Ann N Y Acad Sci; 1977 Mar; 284():34-48. PubMed ID: 212980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preparative synthesis of the antiviral nucleoside 9-beta-D-arabinofuranosyladenine by using bacterial cells].
    ERoshevskaia LA; Baraĭ VN; Zinchenko AI; Kvasiuk EI; Mikhaĭlopulo IA
    Antibiot Med Biotekhnol; 1986 Mar; 31(3):174-8. PubMed ID: 3521466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and properties of the O-methyl derivatives of 9-beta-D-arabinofuranosyladenine.
    Darzynkiewicz E; Kazimierczuk Z; Shugar D
    Cancer Biochem Biophys; 1976 May; 1(4):203-9. PubMed ID: 975022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA.
    McGuigan C; Tollerfield SM; Riley PA
    Nucleic Acids Res; 1989 Aug; 17(15):6065-75. PubMed ID: 2771639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
    Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
    Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
    Smith SH; Shipman C; Drach JC
    Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative cytotoxicity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
    Juranka P; Chan VL
    Cancer Res; 1980 Nov; 40(11):4123-6. PubMed ID: 6162544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.